Company Profile

SANOFI INDIA LTD.

NSE : SANOFIBSE : 500674ISIN CODE : INE058A01010Industry : Pharmaceuticals & DrugsHouse : Sanofi India - MNC
BSE7747.55-3.55 (-0.05 % )
PREV CLOSE (Rs.) 7751.10
OPEN PRICE (Rs.) 7746.00
BID PRICE (QTY) 0.00 (0 )
OFFER PRICE (QTY) 0.00 (0 )
VOLUME 1087
TODAY'S LOW / HIGH (Rs.)7729.20 7816.00
52 WK LOW / HIGH (Rs.)7322.1 8999
NSE7750.10 0.7 (+0.01 % )
PREV CLOSE(Rs.) 7749.40
OPEN PRICE (Rs.) 7839.00
BID PRICE (QTY) 0.00 (0 )
OFFER PRICE (QTY) 0.00 (0 )
VOLUME 15470
TODAY'S LOW / HIGH(Rs.) 7726.95 7839.00
52 WK LOW / HIGH (Rs.)7306 8989

Smart Quotes

1D 1M 3M 1Y 3Y 5Y
STOCK SUMMARY
Trade Value (Rs. in Lacs) 0.00
Dividend Yield(%) 4.71
TTM EPS (Rs.) 233.17
P/E Ratio 33.23
Book Value (Rs.) 1215.00
Face Value (Rs.) 10
MCap (Rs. in Mn) 178430.90
Price/Earning (TTM) 28.83
Price/Sales (TTM) 6.28
Price/Book (MRQ) 6.38
PAT Margin (%) 16.46
ROCE (%) 29.77
Incorporation Year : 1956

Management Info :

Aditya Narayan - Chairman Rajaram Narayanan - Managing Director

Registered Office :

Address : Sanofi House, 117-b,L&t Business Park,Saki Vihar Road, Powai,
Mumbai,
Maharashtra-400072

Phone :

Registrar's Details : Link Intime India Pvt Ltd.
C 101, 247 Park,LBS Marg,Vikhroli (West),Mumbai
Listing : BSE, NSE, MCX
NEWS More
14Apr04-14-2021$Sanofi India informs about board meeting Sanofi India informs about b

Sanofi India has informed about board meeting.

The above information is a part of company’s filings submitted to BSE.

Sanofi India has informed about board meeting.The above informa..
07Apr04-07-2021$Sanofi India informs about certificate Sanofi India informs about c

Sanofi India has informed that the Link Intime India, Registrar and Share Transfer Agent (RTA) of the Company has provided the enclosed certificate for the quarter ended 31st March 2021 under Regulation 74(5) of SEBI (Depositories and Participants) Regulations, 2018.

The above information is a part of company’s filings submitted to BSE.

Sanofi India has informed that the Link Intime India, Registrar..
17Mar03-17-2021$Sanofi India informs about investor webinar presentation Sanofi India informs about i

With reference to letter dated 24th February 2021 intimating the details of the investor webinar which was scheduled today; Sanofi India has informed that the presentation made by the Company at the investor webinar is enclosed for reference under Regulation 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015.

The above information is a part of company’s filings submitted to BSE.

With reference to letter dated 24th February 2021 intimating th..
23Feb02-23-2021$ Appointment / Re-Appointment Of Directors, Re-Appointment Of Chairman Appointment / Re-Appointmen
The Board of Directors of the Company at its Meeting held today, based on recommendation of the Nomination and Remuneration Committee approved the appointment / re-appointment of the following Directors: 1. Re-appointment of Mr. Aditya Narayan as an Independent Director and Chairman 2. Re-appointment of Ms. Usha Thorat as an Independent Director 3. Appointment of Mr. Vaibhav Karandikar as Additional Director and Whole Time Director
The Board of Directors of the Company at its Meeting held today..
08Feb02-08-2021$ Board to consider FY20 results & Final Dividend on February 23, 2021 Board to consider FY20 resu
Sanofi India Ltd has informed BSE that the meeting of the Board of Directors of the Company will be held on February 23, 2021, inter alia, to: 1. Approve the audited accounts for the year ended December 31, 2020. 2. Recommend final dividend for the period mentioned above.
Sanofi India Ltd has informed BSE that the meeting of the Board..
Financials More
Rs. in Millions
QTR Mar 21 ANNUAL 20
Net Profit14594776
Gross Profit 1949 6772
Operating Profit 21578029
Net Sales 725129019
ROLLING FORWARD P/E (EOD)
EVENT CALENDAR
peer group More
Hester Biosciences (BSE)
 2470.05 (11.53%)
M.Cap ( in Cr)
2101.24
Astrazeneca Pharma I (BSE)
 3840.05 (2.70%)
M.Cap ( in Cr)
9600.13
Themis Medicare (BSE)
 497.30 (6.82%)
M.Cap ( in Cr)
456.94
Caplin Point Lab (BSE)
 591.05 (4.82%)
M.Cap ( in Cr)
4470.86
Glaxosmithkline Phar (BSE)
 1503.80 (1.65%)
M.Cap ( in Cr)
25475.28
Shareholding Pattern More
MUTUAL FUNDS/UTI 9.81 %
FI/BANKS/INSURANCE 7.35 %
PROMOTERS 60.4 %
NON-INSTITUTION 10.89 %
GOVERNMENT 0 %
FII 0 %
F & O Quotes